What are empiric therapy regimens for moderate acute bacterial exacerbation of chronic bronchitis (ABECB)?

Updated: Jul 22, 2021
  • Author: Jazeela Fayyaz, DO; Chief Editor: John J Oppenheimer, MD  more...
  • Print


Moderate ABECB and/or any one of the following: age < 65 years, FEV1 >50% predicted, no cardiac disease, or < 3 exacerbations per year:

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!